Sun Pharmaceutical Industries Ltd. closed 10.33% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 11.68% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

In New Jersey, new initiatives support investment and job growth in the artificial intelligence and film and digital media ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

The companies behind the product pulls are Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, all three of which hail from India. The drugmakers are recalling seizure treatments ...

Sun Pharmaceuticals' specialty portfolio may face greater challenges compared to US generics, as the higher existing price points could hinder the ability to transfer additional costs. However ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an FDA-approved PD-L1 inhibitor. Japan's Ono Pharmaceutical bought an antisense ...

Sun Pharmaceutical Industries experienced a notable surge in today's session, climbing 2.03% to reach Rs 1786.50. The stock's movement was marked by a significant increase in trading volume ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have started manufacturing key medicines for such diseases in the country.

ALSO READ: Sensex, Nifty Surge Over 4% in 1 Week: What should investors, traders do? The Nifty 500 and BSE 500 are stock exchanges NSE and BSE's broadest indices, respectively. Top Gainers & Losers: ...

Sun Pharma Advanced Research Company Ltd share price was up by 2.04% from the previous closing price of ₹147.71. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...

On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) for an upfront ...